Observational studyAnnals of African medicine2026
Functional Outcomes of Leukocyte Poor Platelet-rich Plasma Injection in the Treatment of Lateral Epicondylitis of the Elbow.
Observational study in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTennis elbow is common in female elderly patients due to overuse of the forearm and wrist extensors. Platelet-rich plasma (PRP) is a safe, noninvasive modality by which growth factors are produced from platelet concentrates, which helps in the regeneration of damaged tendons. MATERIALS AND
methodsThis prospective observational study assessed leukocyte-poor PRP for lateral epicondylitis in 50 patients unresponsive to conservative treatment. PRP was prepared using a standardized protocol and injected under aseptic conditions. Outcomes were evaluated at baseline, three and 6 months using a Visual Analog Scale (VAS) for pain and patient-related tennis elbow evaluation (PRTEE) for function.
resultsThe mean VAS score improved from 8.8 to 1.7, and the mean PRTEE score improved from 74 to 12.
conclusionLeukocyte poor PRP injection is a minimally invasive, effective and safe outpatient procedure in treating tennis elbow patients with severe pain. Who do not respond to the conservative method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.